ReviewDer Nervenarzt2023
[Transmission routes of neuropathogenic pathogens-Possible mechanisms of neuroinvasion].
Review in Der Nervenarzt, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Forgotten Gate: Choroid Plexus and Blood-CSF Barrier in Arboviral Encephalitis.Life (Basel, Switzerland) · 2026Review
- Analysis of BoDV-1 status, EEG resting-state alpha activity and pro-inflammatory cytokines in adults with and without major depressive disorder.Frontiers in psychology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite natural protective barriers, many human pathogens can penetrate the nervous system. The pathogens have developed sophisticated mechanisms to overturn the privileged immune status of the nervous system. The central nervous system (CNS) has natural barriers and immunological protective mechanisms, such as the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB), that prevent the invasion of pathogens. Bacteria enter the CNS, for example, through transcellular penetration, paracellular entry or via infected leucocytes from the peripheral circulation. Viruses can enter the CNS by hematogenous routes, by direct infection of endothelial cells or by paracellular passage between disrupted endothelial cells (cribriform plate). Also, a few "enhanced barriers", such as the cribriform plate and circumventricular organs (CVO) can serve as entry points for viruses. Viruses can also gain access to the CNS by infection of peripheral nerves. Importantly, most successful neurotropic pathogens are not necessarily restricted to a CNS entry portal. The majority of viral pathogens are of animal origin. Through sometimes sophisticated immune mechanisms for example in bats, highly pathogenic pathogens arose through cross-species transmission. In the last 50 years, various viruses, such as West Nile, Ebola, Marburg, Zika, Nipah and Hendra viruses have also been transmitted from animals to humans. Knowledge of these biological strategies is crucial to hinder, contain or prevent CNS infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.